Clinical Trials in Atlanta

Showing 7501-7520 of 19,805 trials

ALPN-202 With PD-1 Inhibition in Advanced Malignancies

NCT04920383

This is a cohort-based, open-label dose escalation and expansion study in adults with advanced solid tumors or lymphoma.

Advanced Solid TumorLymphoma

Alpine Immune Sciences, Inc.29 participantsStarted Jun 2021

Atlanta, Georgia, United States • Boston, Massachusetts, United States • Grand Rapids, Michigan, United States +2 more locations

RECRUITING< 1 mile

Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort

NCT01574053

Enroll-HD is a longitudinal, observational, multinational study that integrates two former Huntington's disease (HD) registries-REGISTRY in Europe, and COHORT in North America and Australasia-while also expanding to include sites in Latin America. More than 30,000 participants have now enrolled into the study. With annual assessments and no end date, Enroll-HD has built a large and rich database of longitudinal clinical data and biospecimens that form the basis for studies developing tools and biomarkers for progression and prognosis, identifying clinically-relevant phenotypic characteristics, and establishing clearly defined endpoints for interventional studies. Periodic cuts of the database are now available to any interested researcher to use in their research - visit www.enroll-hd.org/for-researchers/access-data/ to learn more.

Huntington's Disease

CHDI Foundation, Inc.35,000 participantsStarted Jul 2012

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Irvine, California, United States +180 more locations

ALPN-202 With PD-1 Inhibition in Advanced Malignancies

Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort

Find Trials by Condition in Atlanta

A Study to Evaluate 3 Dose Levels of Luvadaxistat of Adults With Negative Symptoms of Schizophrenia

HCV-TARGET- Hepatitis C Therapeutic Registry and Research Network

ACS Community Access to Resources Education and Support

An Extension Study of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic Duodenitis

A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 (mFOLFOX6) in Gastric/Gastroesophageal Junction Cancer

A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 in Gastric/Gastroesophageal Cancer

RF Ablation of the Trigone for the Treatment of UUI

A Study to Compare Bempegaldesleukin (BEMPEG: NKTR-214) Combined With Nivolumab and Tyrosine Kinase Inhibitor (TKI) to Nivolumab and TKI Alone in Participants With Previously Untreated Kidney Cancer That is Advanced or Has Spread

Cardionomic STOP-ADHF Study

Trial of Early Therapies During Non-hospitalized Outpatient Window for COVID-19

A Study to Assess BMS-986207 in Combination With Nivolumab and Ipilimumab as First-line Treatment for Participants With Stage IV Non-Small Cell Lung Cancer

NOWDx Test for the Diagnosis of Herpes Simplex Virus Type 2

OCS Lung System EXPAND II Trial

Chemotherapy Induced Peripheral Neuropathy Natural History Study (EPIPHANY)

CASCARA: Castration Sensitive Carboplatin, Cabazitaxel and Abiraterone

A Clinical Trial of PRAX-944 in Participants With Essential Tremor

Evaluation of the Safety and Clinical Performance of the Connected Catheter Study

A Multicenter Study Evaluating AZR-MD-001 in Patients With Meibomian Gland Dysfunction and Evaporative Dry Eye Disease (DED)